Montecito Bank & Trust’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.3M Buy
64,595
+1,800
+3% +$37K 0.2% 111
2026
Q2
$1.31M Buy
62,795
+5,103
+9% +$106K 0.2% 116
2026
Q1
$1.21M Buy
57,692
+10,588
+22% +$224K 0.2% 116
2025
Q4
$996K Buy
47,104
+14,301
+44% +$303K 0.16% 130
2025
Q3
$696K Buy
+32,803
New +$691K 0.11% 178
2025
Q1
$766K Buy
36,917
+338
+0.9% +$6.94K 0.14% 158
2024
Q4
$744K Hold
36,579
– – 0.13% 158
2024
Q3
$776K Buy
36,579
+11,706
+47% +$244K 0.13% 153
2024
Q2
$505K Buy
24,873
+9,939
+67% +$201K 0.1% 179
2024
Q1
$306K Buy
+14,934
New +$305K 0.06% 232

Other funds holding IBDW

Montecito Bank & Trust's IBDW Position: Q3 2026 in Review

Montecito Bank & Trust increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 2.9% in Q3 2026, buying an estimated $37K and bringing the position to 64,595 shares worth $1.3M. The position accounts for 0.2% of the portfolio, ranked #111.

Montecito Bank & Trust first reported a position in IBDW in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.31M in Q2 2026. 282 funds tracked by Wall St. Rank hold IBDW as of Q3 2026.

  • Montecito Bank & Trust held 64,595 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $1.3M as of Q3 2026.
  • Montecito Bank & Trust bought 1,800 iShares iBonds Dec 2031 Term Corporate ETF shares in Q3 2026, an estimated $37K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.2% of Montecito Bank & Trust's portfolio in Q3 2026, its #111 holding.
  • Montecito Bank & Trust first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Montecito Bank & Trust's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $1.31M in Q2 2026.
  • 282 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q3 2026.

Based on Montecito Bank & Trust's 13F filing for Q3 2026, filed 1 Oct 2026.